Aptevo Therapeutics (APVO) Assets (2015 - 2026)
Aptevo Therapeutics (APVO) posted Assets of $19.9 million for Q1 2026, down 26.81% sequentially from $27.2 million in Q4 2025, and up 138.58% YoY from $8.3 million in Q1 2025.
Aptevo Therapeutics (APVO) Assets (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Assets for 12 years, with the latest figure at $19.9 million in Q1 2026.
- Quarterly Assets rose 138.58% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (up 138.58% YoY) and the FY2025 annual result came in at $27.2 million, up 74.42% from the prior year.
- Assets declined to $19.9 million in Q1 2026 per APVO's latest filing, from $27.2 million in the prior quarter.
- Over five years, Assets peaked at $45.2 million in Q1 2022 and troughed at $8.3 million in Q1 2025.
- A 5-year average of $25.1 million and a median of $27.0 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2025 and 2026: Assets sank 52.68% in 2025, then jumped 138.58% in 2026.
- Over 5 years, Assets stood at $34.2 million in 2022, then declined by 27.39% to $24.8 million in 2023, then plunged by 37.24% to $15.6 million in 2024, then surged by 74.42% to $27.2 million in 2025, then slipped by 26.81% to $19.9 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $19.9 million, $27.2 million, and $27.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 19.82 Bn |
| 10 | Aptevo Therapeutics | 3.29 Mn | -6.51 Mn | - | 14.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.52 Mn |
| Mar 31, 2026 | 19.90 Mn |
| Dec 31, 2025 | 27.19 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 15.62 Mn |
| Mar 31, 2025 | 8.34 Mn |
| Dec 31, 2024 | 15.59 Mn |
| Sep 30, 2024 | 15.15 Mn |
| Jun 30, 2024 | 14.92 Mn |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 24.84 Mn |
| Sep 30, 2023 | 27.13 Mn |
| Jun 30, 2023 | 28.91 Mn |
| Mar 31, 2023 | 34.97 Mn |
| Dec 31, 2022 | 34.22 Mn |
| Sep 30, 2022 | 31.70 Mn |
| Jun 30, 2022 | 38.80 Mn |
| Mar 31, 2022 | 45.18 Mn |
| Dec 31, 2021 | 56.60 Mn |
| Sep 30, 2021 | 64.01 Mn |